Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

70.74
Delayed Data
As of Dec 09
 -1.22 / -1.70%
Today’s Change
46.52
Today|||52-Week Range
117.12
-36.94%
Year-to-Date

Today’s Trading

Previous close71.96
Today’s open72.66
Day’s range70.03 - 75.01
Volume539,833
Average volume (3 months)608,990
Market cap$2.9B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-76.00%
Earnings growth (this year)-55.08%
Earnings growth (next 5 years)+30.06%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.18

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...-3.13-2.65%
GLPGGalapagos NV+0.06+0.10%
CTLTCatalent Inc+0.19+0.78%
ICPTIntercept Pharmaceut...+3.30+3.21%
Data as of 4:01pm ET, 12/09/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$1.72
Annual revenue (last year)$0.00
Annual profit (last year)-$145.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, Senior VP &
Head-Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts


Search for Jobs